Skip to content

Clinical trials

Terminated Myelodysplastic Syndromes trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myelodysplastic Syndromes Status: Terminated Country / region: Netherlands Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20061
20071
20091
20111
20151
20161
20171
20181
20202
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated12

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Kiadis Pharma2
Amgen1
European Society for Blood and Marrow Transplantation1
Genzyme, a Sanofi Company1
Gilead Sciences1
Goethe University1
Incyte Corporation1
Janssen Research & Development, LLC1
Novartis Pharmaceuticals1
Radboud University Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myelodysplastic Syndromes12
Leukemia, Myeloid, Acute4
Hematologic Neoplasms3
Precursor Cell Lymphoblastic Leukemia-Lymphoma3
Graft vs Host Disease2
Leukemia, Myeloid2
Lymphoma2
Leukemia, Lymphoid1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive1
Leukemia, Myelomonocytic, Chronic1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.